直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

European IP Blog

UPC: “Human Necessities” Heard in Paris, “Chemistry and Metallurgy” in Munich Central Division

May 16, 2023

Authored and Edited by Dr. Antje Brambrink; Dr. Moritz Meckel

Shortly before its start, the Presidium of the UPC has decided to split the competences for the technical fields formerly envisioned for a London branch of the Central Division.

As of June 1, 2023, all cases brought before the Central Division relating to patents on:

  • Human necessities (IPC section A, which covers e.g., health, agriculture, foods, tobacco, etc.) shall be dealt with by the Paris seat;
  • Chemistry, metallurgy (IPC section C) will be assigned to the Munich section.

This long-awaited decision provides a provisional assignment until a final decision on the establishment of another seat of the Central Division will be reached by the Administrative Committee of the UPC. Originally London was the place where those cases were supposed to be heard (Art. 7(2) in conjunction with Annex II of the UPC-Agreement). After Brexit it had been unclear how the UPC would handle this. Milan was discussed as potential successor of the Central Division’s London seat. It remains to be seen how this will develop in the future.

For more information, visit our Insights:

Unified Patent Court FAQ

Unitary Patent FAQ

Strategic Considerations for Opting in or out of the Unified Patent Court

Tags

Unified Patent Court (UPC)

Related Offices

Munich

Contacts

Dr. Antje Brambrink
Partner
Munich
+49 89 83931 1239
Email
Dr. Moritz Meckel
Partner
Munich
+49 89 83931 1235
Email

Copyright © 2023 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

2026 FCBA Global Series Fall Session

October 14-16, 2026

Dublin

Webinar

FRAND Rate Setting and Negotiation Conduct: U.S., UK, EU, and China

August 13, 2026

Webinar

European IP Blog

UPC Action Permissibly Lodged Prior to the Grant of a European Patent

12 August 2026

Webinar

Chutian Safeguard Series Navigating U.S. Section 337 Investigations and UPC Patent Litigation in Europe

July 24, 2026

Webinar

Webinar

Inventive Step in Europe and the US: Comparing the UPC, EPO and National Approaches

July 8, 2026

Webinar

Lecture

Munich Licensing Summer Course 2026

June 18-19, 2026

Munich

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP